The American Academy of Ophthalmology is holding its annual meeting right now in San Francisco. Many "researchers" will be reporting the results of their research. Watch out for "too much information" over the internet!
VEGF Trap-Eye is a new injectable medication that blocks VEGF for the treatment of wet macular degeneration. It may be as good as Lucentis, but not given as often.
VEGF-Trap (aka aflibercept), another anti-VEGF drug, moves closer to FDA approval as it received “priority review” status. This status means that the FDA process will be […]
VEGF Trap Eye is another anti-VEGF medication to be injected into the eye for the treatment of wet macular degeneration. The FDA did not approve recently, but will reconsider by November!